About CHEORS
CHEORS is a company based in North Wales (United States) founded in 2015 was acquired by PharmAlliance in April 2024. The company has 22 employees as of March 30, 2024. CHEORS operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter North Wales, United States
- Employees 22 as on 30 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Complete Heor Solutions India Private Limited
- Date of Incorporation 23 Jun, 2015
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$1.38 M (USD)24.68as on Mar 31, 2022
-
Net Profit
$159.6 K (USD)20.26as on Mar 31, 2022
-
EBITDA
$211.78 K (USD)12.09as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
22
as on Mar 30, 2024
-
Acquired by
PharmAlliance
(Apr 16, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CHEORS
Detailed funding history for CHEORS
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CHEORS
CHEORS has secured backing from 1 investor. Prominent investors backing the company include PharmAlliance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for CHEORS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CHEORS
Investment portfolio details for CHEORS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CHEORS
Detailed financials for CHEORS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cheors Comparisons
Peer comparison for CHEORS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CHEORS
CHEORS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
Detailed competitors of CHEORS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cheors
Complete news archive for CHEORS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CHEORS
CHEORS was founded in 2015.
CHEORS is headquartered in North Wales, United States. It is registered at North Wales, Pennsylvania, United States.
Mark Bouck is the current CEO of CHEORS.
As of Mar 30, 2024, the latest employee count at CHEORS is 22.
Annual revenue of CHEORS is $1.38M as on Mar 31, 2022.
CHEORS was founded in 2015 and is based in North Wales, United States. Health economics outcomes and research solutions are offered to the pharmaceutical and biotech sectors, with a focus on market access services, early decision models, and customized payer tools. The company was recently acquired by PharmAlliance, through which operations in the healthcare industry are continued.
CHEORS's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
CHEORS has 1 investor. Key investors include PharmAlliance.